Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI reads your face to measure pain: a new test for chronic sufferers?

NCT ID NCT04896827

First seen May 30, 2026 · Last updated Jun 22, 2026 · Updated 3 times

Summary

This study aims to develop a facial recognition system powered by artificial intelligence to automatically measure pain and how well the body controls it. Researchers will test healthy volunteers and people with chronic pain using a heat and cold water test while cameras capture their facial expressions. The goal is to create a simple, objective screening tool for pain control problems, which could help diagnose and understand chronic pain better.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Université de Sherbrooke

    Sherbrooke, Quebec, J1H 5N4, Canada

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a simple, automated way to measure pain and identify pain control problems using just a camera.

What could go wrong

This is an early-stage, suspended study focused on developing a test, not a treatment. The technology may not be accurate enough for clinical use.

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.